India Digest: Aereo snags $15m from 360 ONE; Zensar acquires US firm

Drone-based business intelligence provider Aereo has raised $15 million in a Series B round of funding led by 360 ONE (IIFL). Separately, Zensar Technologies has announced the acquisition of BridgeView Life Sciences, an American IT and operations services firm, in an all-cash deal.

Aereo snags $15m from 360 ONE

Drone-based business intelligence provider Aereo has raised $15 million in a Series B round of funding led by 360 ONE (IIFL). Aereo uses proprietary drones and an AI-powered data analytics platform to manage large capital assets in sectors like mining, infrastructure, and land records. It claims to have achieved a 400% revenue growth in the last two years.

The firm plans to use the funding to fuel Aereo’s focus on automation and enhance its breadth of enterprise applications. The funds will be used to augment their AI-powered drone data analytics platform, expand strategic partnerships, and drive research and development for new product innovations.

Additionally, funds will support business expansion both within India and overseas, targeting markets in Latin America, Central Africa, and Southeast Asia.

Zensar acquires BridgeView Life Sciences

Zensar Technologies, an RPG Group company headquartered in Pune, has acquired BridgeView Life Sciences, an American IT and operations services firm, in an all-cash deal.

The deal will help Zensar strengthen its healthcare and life sciences vertical, it said in a statement.

While the overall deal size is $25 million, Zensar will provide $14 million in upfront payment. It will pay the remaining amount by 31 December 2027, subject to BridgeView meeting specific performance and employment milestones, according to its regulatory filings.

“This acquisition deepens our services for existing clients and expands into new areas, especially for innovators and emerging pharma players underserved by technology,” Anant Goenka, Vice-Chairman of RPG Enterprises and Zensar Technologies, said in a statement.

Go to Source